These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35130054)

  • 1. Regular Acetaminophen Use and Blood Pressure in People With Hypertension: The PATH-BP Trial.
    MacIntyre IM; Turtle EJ; Farrah TE; Graham C; Dear JW; Webb DJ;
    Circulation; 2022 Feb; 145(6):416-423. PubMed ID: 35130054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of allopurinol on blood pressure of adolescents with newly diagnosed essential hypertension: a randomized trial.
    Feig DI; Soletsky B; Johnson RJ
    JAMA; 2008 Aug; 300(8):924-32. PubMed ID: 18728266
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of Masked Hypertension with a Chinese Herbal Formula: A Randomized, Placebo-Controlled Trial.
    Zhang DY; Cheng YB; Guo QH; Shan XL; Wei FF; Lu F; Sheng CS; Huang QF; Yang CH; Li Y; Wang JG
    Circulation; 2020 Nov; 142(19):1821-1830. PubMed ID: 33019798
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antihyperglycemic and Blood Pressure Effects of Empagliflozin in Black Patients With Type 2 Diabetes Mellitus and Hypertension.
    Ferdinand KC; Izzo JL; Lee J; Meng L; George J; Salsali A; Seman L
    Circulation; 2019 Apr; 139(18):2098-2109. PubMed ID: 30786754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy and safety of LCZ696, a first-in-class angiotensin receptor neprilysin inhibitor, in Asian patients with hypertension: a randomized, double-blind, placebo-controlled study.
    Kario K; Sun N; Chiang FT; Supasyndh O; Baek SH; Inubushi-Molessa A; Zhang Y; Gotou H; Lefkowitz M; Zhang J
    Hypertension; 2014 Apr; 63(4):698-705. PubMed ID: 24446062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of Oral Butyrate on Blood Pressure in Patients With Hypertension: A Randomized, Placebo-Controlled Trial.
    Verhaar BJH; Wijdeveld M; Wortelboer K; Rampanelli E; Levels JHM; Collard D; Cammenga M; Nageswaran V; Haghikia A; Landmesser U; Li XS; DiDonato JA; Hazen SL; Garrelds IM; Danser AHJ; van den Born BH; Nieuwdorp M; Muller M
    Hypertension; 2024 Oct; 81(10):2124-2136. PubMed ID: 39034917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ambulatory versus clinic blood pressure for the assessment of anti hypertensive efficacy in clinical trials: insights from the Val-Syst Study.
    Palatini P; Dorigatti F; Mugellini A; Spagnuolo V; Varì N; Ferrara R; Bertocchi F
    Clin Ther; 2004 Sep; 26(9):1436-45. PubMed ID: 15531006
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of Febuxostat on Ambulatory Blood Pressure in Subjects With Hyperuricemia and Hypertension: A Phase 2 Randomized Placebo-Controlled Study.
    Gunawardhana L; McLean L; Punzi HA; Hunt B; Palmer RN; Whelton A; Feig DI
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29102979
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A multicenter, randomized, double-blind comparison of the efficacy and safety of irbesartan and enalapril in adults with mild to moderate essential hypertension, as assessed by ambulatory blood pressure monitoring: the MAPAVEL Study (Monitorización Ambulatoria Presión Arterial APROVEL).
    Coca A; Calvo C; García-Puig J; Gil-Extremera B; Aguilera MT; de la Sierra A; Martín-Hidalgo A; Marín R;
    Clin Ther; 2002 Jan; 24(1):126-38. PubMed ID: 11833827
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dietary nitrate provides sustained blood pressure lowering in hypertensive patients: a randomized, phase 2, double-blind, placebo-controlled study.
    Kapil V; Khambata RS; Robertson A; Caulfield MJ; Ahluwalia A
    Hypertension; 2015 Feb; 65(2):320-7. PubMed ID: 25421976
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Main results of the ouabain and adducin for Specific Intervention on Sodium in Hypertension Trial (OASIS-HT): a randomized placebo-controlled phase-2 dose-finding study of rostafuroxin.
    Staessen JA; Thijs L; Stolarz-Skrzypek K; Bacchieri A; Barton J; Espositi ED; de Leeuw PW; Dłużniewski M; Glorioso N; Januszewicz A; Manunta P; Milyagin V; Nikitin Y; Souček M; Lanzani C; Citterio L; Timio M; Tykarski A; Ferrari P; Valentini G; Kawecka-Jaszcz K; Bianchi G
    Trials; 2011 Jan; 12():13. PubMed ID: 21235787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ibuprofen interferes with the efficacy of antihypertensive drugs. A randomized, double-blind, placebo-controlled trial of ibuprofen compared with acetaminophen.
    Radack KL; Deck CC; Bloomfield SS
    Ann Intern Med; 1987 Nov; 107(5):628-35. PubMed ID: 2889416
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized Dose-Response Study of the New Dual Endothelin Receptor Antagonist Aprocitentan in Hypertension.
    Verweij P; Danaietash P; Flamion B; Ménard J; Bellet M
    Hypertension; 2020 Apr; 75(4):956-965. PubMed ID: 32063059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ambulatory monitoring uncorrected for placebo overestimates long-term antihypertensive action. Systolic Hypertension in Europe (SYST-EUR) Trial Investigators.
    Staessen JA; Thijs L; Bieniaszewski L; O'Brien ET; Palatini P; Davidson C; Dobovisek J; Jääskivi M; Laks T; Lehtonen A; Vanhanen H; Webster J; Fagard R
    Hypertension; 1996 Mar; 27(3 Pt 1):414-20. PubMed ID: 8698447
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of combination olmesartan medoxomil plus azelnidipine versus monotherapy with either agent on 24-hour ambulatory blood pressure and pulse rate in Japanese patients with essential hypertension: additional results from the REZALT study.
    Shimada K; Ogihara T; Saruta T; Kuramoto K;
    Clin Ther; 2010 May; 32(5):861-81. PubMed ID: 20685495
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Triple therapy with olmesartan medoxomil, amlodipine besylate, and hydrochlorothiazide in adult patients with hypertension: The TRINITY multicenter, randomized, double-blind, 12-week, parallel-group study.
    Oparil S; Melino M; Lee J; Fernandez V; Heyrman R
    Clin Ther; 2010 Jul; 32(7):1252-69. PubMed ID: 20678674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The combination of olmesartan medoxomil and amlodipine besylate in controlling high blood pressure: COACH, a randomized, double-blind, placebo-controlled, 8-week factorial efficacy and safety study.
    Chrysant SG; Melino M; Karki S; Lee J; Heyrman R
    Clin Ther; 2008 Apr; 30(4):587-604. PubMed ID: 18498909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of vitamin D on blood pressure and cardiovascular risk factors: a randomized controlled trial.
    Pilz S; Gaksch M; Kienreich K; Grübler M; Verheyen N; Fahrleitner-Pammer A; Treiber G; Drechsler C; Ó Hartaigh B; Obermayer-Pietsch B; Schwetz V; Aberer F; Mader J; Scharnagl H; Meinitzer A; Lerchbaum E; Dekker JM; Zittermann A; März W; Tomaschitz A
    Hypertension; 2015 Jun; 65(6):1195-201. PubMed ID: 25801871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronotherapy for hypertension in obstructive sleep apnoea (CHOSA): a randomised, double-blind, placebo-controlled crossover trial.
    Serinel Y; Yee BJ; Grunstein RR; Wong KH; Cistulli PA; Arima H; Phillips CL
    Thorax; 2017 Jun; 72(6):550-558. PubMed ID: 27974526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting cardiovascular risk using conventional vs ambulatory blood pressure in older patients with systolic hypertension. Systolic Hypertension in Europe Trial Investigators.
    Staessen JA; Thijs L; Fagard R; O'Brien ET; Clement D; de Leeuw PW; Mancia G; Nachev C; Palatini P; Parati G; Tuomilehto J; Webster J
    JAMA; 1999 Aug; 282(6):539-46. PubMed ID: 10450715
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.